Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: Member Spotlight

Eyes on Washington: Federal Health Care Grant Notification Service

Monday, August 7, 2017   (0 Comments)
Posted by: Kayla Barna
Share |

Grant Opportunities for July 31, 2017 through August 4, 2017

 

New Federal health care grant opportunities announced for:

 

·       U.S. Department of Health and Human Services (hhs)

·       U.S. Agency for International Development (usaid)

·       U.S. Department of State (dos)

 

United States Department of Health and Human Services Funding Opportunity Announcements:

 

HHS: Cardiovascular and Pulmonary Research on E-Cigarettes (R01)

Funding Opportunity Number: RFA-HL-18-024

The purpose of this funding opportunity announcement (FOA) is to stimulate research on cardiovascular and pulmonary physiologic and health effects of electronic cigarette (e-cigarette) exposure. This FOA invites applications addressing the effects of e-cigarettes on the cardiovascular and pulmonary systems, alone or in combination. Studies involving clinical populations, animal models and/or cell preparations would all be considered responsive. Research may examine the effects of the whole e-cigarette aerosol or of individual components or constituents. Research may also examine where aerosols, components, or constituents deposit in the airways and resulting heart and/or lung consequences.  This funding opportunity was announced on August 1, 2017. The application deadline is January 16, 2018. For more information, see the “Related Documents” tab on the Grant Opportunity Page. 

 

HHS: Administrative supplements for validation studies of analytical methods for dietary supplements and natural products

Funding Opportunity Number: PA-17-447

The reproducibility and comparability of dietary supplement research is enhanced through rigorous analytical characterization of key experimental materials. The publication of analytical methods which have been thoroughly validated for specific, precise, accurate, and sensitive quantitative determination of chemical constituents of dietary supplements therefore makes critical contributions to the rigor and reproducibility of biomedical research. This FOA will build on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of relevant quantitative analytical methods. The methods proposed for validation must be used to identify and quantify chemical constituents (active or marker chemical compounds, adulterants, contaminants) or metabolites thereof in experimental reagents, raw materials, and/or clinical specimens (for example urine or plasma samples). Methods must have been developed or utilized in fulfillment of the active parent grants specific aims. Candidate constituents for quantitative method validation studies may include (but are not limited to): phytochemicals, nutrients, and potentially deleterious substances such as pesticides and mycotoxins. Multi-laboratory validation studies will not be supported through this FOA. This funding opportunity was announced on August 1, 2017. The application deadline is April 15, 2018. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Metabolomic Data Analysis and Interpretation Tools (U01)         

Funding Opportunity Number: RFA-RM-17-012

The goal of this cooperative agreement Funding Opportunity Announcement (FOA) is to address key challenges in analyzing and interpreting metabolomics data by developing novel tools to facilitate metabolomics data analysis and interpretation. Specifically, successful awardees will develop new or enhanced computational approaches or tools that facilitate metabolomics data analysis, interpretation, and integration. Generalizable, scalable, and portable solutions appropriate for scientists with limited expertise in informatics are particularly encouraged. Projects are not intended to supplement ongoing metabolomics analyses, but to provide tools for broader use by the biomedical research community.  This funding opportunity was announced on August 1, 2017. The application deadline is October 20, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R21)         

Funding Opportunity Number: PA-17-448

The purpose of this FOA is to support investigator-initiated R21 applications that will inform our understanding of the typical and atypical patterns of language and literacy development of dual language learners (DLLs) in the United States. Applicants are encouraged to take advantage of advances in the language sciences and related fields to identify and clarify specific cognitive, linguistic, neurobiological, and sociocultural factors associated with normal and impaired language and literacy acquisition in young DLL populations.  This funding opportunity was announced on August 1, 2017. The application deadline is September 7, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R01)

Funding Opportunity Number: PA-17-443

The purpose of this FOA is to support investigator-initiated R01 applications that will inform our understanding of the typical and atypical patterns of language and literacy development of dual language learners (DLLs) in the United States. Applicants are encouraged to take advantage of advances in the language sciences and related fields to identify and clarify specific cognitive, linguistic, neurobiological, and sociocultural factors associated with normal and impaired language and literacy acquisition in young DLL populations.  This funding opportunity was announced on August 1, 2017. The application deadline is September 7, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: National Metabolomics Data Repository (NMDR) (U2C)    

Funding Opportunity Number: RFA-RM-17-011

This Funding Opportunity Announcement (FOA) addresses the need for a robust National Metabolomics Data Repository to store, and makes publicly available, raw and processed metabolomic data generated by large NIH programs, individual research grants, and other biomedical research groups. Data, associated metadata, and the essential tools critical for accessing the key information will be housed in a cloud computing environment accessible for searching and reanalysis by the biomedical research community. The Metabolomics Data Repository and Coordination Center (DRCC), created in Stage I of the Common Fund Metabolomics Program, have begun to address this need. In the transition to a National Metabolomics Data Repository, the successful applicant is expected to continue and enhance the current technical capabilities of the Data Repository and create a governance structure that engages the wider metabolomics community to guide the repository’s efforts toward continual technical improvement and expansion and policy development for data deposition, access, and citation. This funding opportunity was announced on August 1, 2017. The application deadline is October 20, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Closing the Gap between Standards Development and Implementation-Maturing the Consolidated Clinical Document Architecture (C-CDA) and Fast Healthcare Interoperability Resources (FHIR) Standard        

Funding Opportunity Number: NAP-AX-17-004

When a computer system receives electronic health information from another system, it needs to be able to process the information without time-consuming human intervention. This can only occur if the sending system has used a consistent data format.  Given the vast number of systems that exchange electronic health information expecting each to negotiate agreed-upon exchange formats with all other systems with which it interacts is impractical. To address this issue, stakeholders in the health IT ecosystem have organized themselves under the auspices of standards development organizations (SDOs) to develop standardized data formats pertaining to specific purposes. These organizations include, but are not limited to: Health Level 7 International (HL7), the National Council for Prescription Drug Plans (NCPDP) and Integrating the Healthcare Enterprise (IHE). SDOs are primarily responsible for developing and maintaining the technical standards and any accompanying implementation specifications/profiles that provide additional implementation instructions to developers based on the particular purpose for which the standard is intended to be used. This funding opportunity was announced on August 1, 2017. The application deadline is August 31, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)       

Funding Opportunity Number: PA-17-444

This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Applications may propose studies using either single or mixed methods. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.  This funding opportunity was announced on August 1, 2017. The application deadline is September 7, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Stakeholder Engagement and Program Coordination Center (SEPCC) (U2C)      

Funding Opportunity Number: RFA-RM-17-014

This Funding Opportunity Announcement (FOA) solicits applications to establish a Stakeholder Engagement and Program Coordination Center (SEPCC) to coordinate the required activities of the Common Fund Metabolomics Program Consortium; to engage the stakeholder community in identifying and developing strategies to address outstanding concerns in the application of metabolomics to biomedical research; and to promote use of Consortium resources by the greater biomedical research community. The Common Fund Metabolomics Program views community engagement and multi-directional communication as essential to overcome challenges in realizing the potential of metabolomics in biomedical research. This funding opportunity was announced on August 1, 2017. The application deadline is October 20, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Compound Identification Development Cores (U2C)       

Funding Opportunity Number: RFA-RM-17-013

This Funding Opportunity Announcement (FOA) invites applications to establish Compound Identification Development Cores (CIDC) to develop innovative approaches to enhance compound identification of the most significant, biomedically-relevant unknown metabolites. The ultimate goal of this FOA is to expand the repertoire of biologically relevant compounds that can be quickly and inexpensively identified in high throughput metabolomics experiments. An interdisciplinary approach and partnership among metabolomics experts, biomedical researchers, chemists, and computational experts will be integral to the success of this goal, and advances made through this initiative are expected to be catalytic to the field. This funding opportunity was announced on August 1, 2017. The application deadline is October 20, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)        

Funding Opportunity Number: PA-17-445

This Funding Opportunity Announcement (FOA) invites Small Research Grant (R03) applications to study the ethical, legal and social implications (ELSI) of human genome research. These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data and the secondary analysis of existing data. This funding opportunity was announced on August 1, 2017. The application deadline is September 7, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21) 

Funding Opportunity Number: PA-17-446

This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. These applications should propose single or mixed methods studies that break new ground, extend previous discoveries in new directions or develop preliminary data in preparation for larger studies. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information.  This funding opportunity was announced on August 1, 2017. The application deadline is September 7, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Accelerating the Prevention and Control of HIV, Viral Hepatitis, STDs and TB in the U.S.-Affiliated Pacific Islands

Funding Opportunity Number: CDC-RFA-PS18-1801

This integrated Funding Opportunity Announcement (FOA) is supported by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) and aims to: Promote program collaboration and services integration to capitalize on the opportunity to diagnose, treat, and prevent HIV, STD, TB, and VH in persons with similar risk factors.  Improve collection, sharing, reporting, analysis, interpretation, and use of surveillance data.  Assure implementation of policies and plans that will make effective use of resources to improve health outcomes.  Develop the public health care workforce through training and education.  Improve public health laboratory capacity.  Enhance prevention, care, follow-up and treatment for disease-specific activities. Reduce administrative burdens of managing multiple cooperative agreements by consolidating the application and award process as well as streamlining the reporting requirements. This funding opportunity was announced on August 1, 2017. The application deadline is October 2, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Strengthening the Quality, Accessibility, and Sustainability of the National Health Laboratory Services (NHLS) in United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)       

Funding Opportunity Number: CDC-RFA-GH18-1812

Timely and reliable laboratory data are an essential component of a well-functioning national health system. This FOA will support strengthening the quality, accessibility, and sustainability of the NHLS across a six-tiered network, i.e., at the national, zonal, regional, district, health center, and dispensary levels. Technical assistance will focus on improving the quality assurance of HIV rapid testing, TB microscopy and GeneXpert; Early Infant Diagnosis (EID) and Viral Load (VL) testing; establishment and maintenance of efficient sample referral system and transport networks; implementation of laboratory Quality Management Systems; implementation of Laboratory Information Management Systems; scale up of EID and VL monitoring programs; quantification and forecasting of laboratory commodities; HIV Drug Resistance Surveillance; and, effective use of laboratory data for program management. This funding opportunity was announced on August 2, 2017. The application deadline is October 2, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Supporting Antiretroviral Treatment through Improved Information, Linkage, and Quality of Care in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR)        

Funding Opportunity Number: CDC-RFA-GH18-1817 

The key element of the national HIV/AIDS program is ART scale up contributing towards strategic goals of treatment cascade. This project will build on the successful creation of a HIV medical information system through the ACCESS project by scaling up implementation of the MIS to treatment sites in all 12 PEPFAR focus oblasts, including capacity building of healthcare workers, improving information management, analysis and use. The project will also develop and implement a laboratory information system module. In addition, the project will work with the treatment sites to implement quality improvement and facility index testing activities in coordination with other PEPFAR and Global Fund supported activities. The major expected project results are 1) functional HIV MIS is operated by a GOU affiliated Operator at treatment sites in the 12 PEPFAR priority regions and Vinnitsa; 2) MIS data used by sites, GoU, PEPFAR, and other stakeholders; 3) laboratory module implemented; 3) quality improvement activities are implemented at all supported treatment sites; 4) high coverage facility index testing is performed at supported sites.  This funding opportunity was announced on August 2, 2017. The application deadline is October 2, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: NINR Exploratory Center (P20)    

Funding Opportunity Number: RFA-NR-17-002

This Funding Opportunity Announcement invites applications to establish NINR P20 Exploratory Centers. The P20 mechanism is used to support planning for new programs, expansion or modification of existing resources, and studies to explore various approaches to the development of interdisciplinary programs that offer potential solutions to problems of special significance to the mission of the NIH. The P20 may lead to Center sustainability and/or the ability to be funded through other specialized or comprehensive grants. This funding opportunity was announced on August 2, 2017. The application deadline is November 30, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment (U01) 

Funding Opportunity Number: RFA-CA-17-029

The purpose of this initiative is to establish an Academic-Industrial Partnership Program to develop new and/or validate existing technologies, methods, and assays for the capture and quantification of tumor associated cells, DNA, RNA, or exosomes in body fluids of patients with early stage disease or those at high risk; as well as distinguishing cancer from benign disease; or aggressive from indolent cancers. The precompetitive alliances with industry will harmonize and validate technologies, methods and assays associated with liquid biopsies. This funding opportunity was announced on August 2, 2017. The application deadline is January 23, 2018. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: NINR Center of Excellence (P30) 

Funding Opportunity Number: RFA-NR-17-003

This Funding Opportunity Announcement invites applications to establish NINR P30 Center of Excellence. The P30 mechanism is used to support planning for new programs, expansion or modification of existing resources, and studies to explore various approaches to the development of interdisciplinary programs that offer potential solutions to problems of special significance to the mission of the NIH. The P30 may lead to Center sustainability and/or the ability to be funded through other specialized or comprehensive grants. The purpose of this program is to support NINR P30 Centers of Excellence to enhance interdisciplinary, biobehavioral research for scientists conducting research in multiple complex chronic conditions in human adult populations. This FOA is specifically designed with the intent to support the NINR Common Data Element (CDE) initiative.  This funding opportunity was announced on August 2, 2017. The application deadline is November 30, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Pharmacogenomics of Anti-retroviral Therapy in People Who Inject Drugs (R01)

Funding Opportunity Number: RFA-DA-18-014

The purpose of this funding opportunity is to identify genetic and epigenetic factors that affect the recovery of the CD4+ T cells in response to anti-retroviral therapy in HIV infected people who inject drugs infected. This funding opportunity was announced on August 3, 2017. The application deadline is December 14, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: HIV-associated neuropathic pain and opioid interaction (R01)     

Funding Opportunity Number: RFA-DA-18-015

The purpose of this RFA is to promote research investigating the underlying mechanisms by which opioids including prescription drugs exacerbate HIV-associated neuropathic pain. Results from these studies may help obtain information for developing safe and effective treatments of neuropathic pain for HIV-infected patients exposed to opioids.  This funding opportunity was announced on August 3, 2017. The application deadline is December 18, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Point of Care Technologies Research Network: Point of Care Centers (U54)

Funding Opportunity Number: PAR-17-453

The purpose of this funding opportunity announcement is to solicit Research Center applications for the Point-of-Care Technologies Research Network (POCTRN). POCTRNs purpose is to drive the development and application of appropriate point of care technologies through collaborative efforts that merge scientific and technological capabilities with clinical need. The POCTRN Research Centers will create a national research network that works to build expertise in the development of integrated systems that address unmet clinical needs in point-of-care testing and treatment through the creation of multidisciplinary partnerships. This opportunity is open to existing POCTRN grantees as well as new applicants. This funding opportunity was announced on August 3, 2017. The application deadline is January 7, 2018. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Pregnancy in Women with Disabilities (R01)        

Funding Opportunity Number: PA-17-452

This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages research project grants (R01) investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with physical, intellectual and developmental, and/or sensory disabilities and their families. Applicants are encouraged to include women with disabilities and members of the community in the design and conduct of their research.  This funding opportunity was announced on August 3, 2017. The application deadline is September 7, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Pregnancy in Women with Disabilities (R03)

Funding Opportunity Number: PA-17-451

This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages small research project grants (R03) investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with physical, intellectual and developmental, and/or sensory disabilities and their families. Applicants are encouraged to include women with disabilities and members of the community in the design and conduct of their research. This funding opportunity was announced on August 3, 2017. The application deadline is September 7, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01)           

Funding Opportunity Number: RFA-RM-17-029

The Common Fund Program - Accelerating Translation of Glycoscience: Integration and Accessibility - aims to develop accessible and affordable new tools and technologies for studying carbohydrates that will allow biomedical researchers to significantly advance our understanding of the roles of these complex molecules in health and disease. This program will enable investigators who might not otherwise conduct research in the glycosciences, to undertake the study of carbohydrate structure and function. This funding opportunity was announced on August 4, 2017. The application deadline is October 27, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01)

Funding Opportunity Number: RFA-RM-17-030

The Common Fund Program - Accelerating Translation of Glycoscience: Integration and Accessibility - aims to develop accessible and affordable new tools and technologies for studying carbohydrates that will allow biomedical researchers to significantly advance our understanding of the roles of these complex molecules in health and disease. This program will enable investigators who might not otherwise conduct research in the glycosciences, to undertake the study of carbohydrate structure and function.  This funding opportunity was announced on August 4, 2017. The application deadline is October 27, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: Collaborative Research Network for Fusion Oncoproteins in Childhood Cancers (U54)

Funding Opportunity Number: RFA-CA-17-049

This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research on fusion oncoproteins in childhood cancers. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Recommendation E. Intensify research on the major drivers of childhood cancers: Improve our understanding of fusion oncoproteins in pediatric cancer and use new preclinical models to develop inhibitors that target them. The goal of this FOA is to establish a consortium of collaborating research teams to advance our understanding of the biology and mechanisms of action of fusion oncoproteins in pediatric cancers, and to apply this knowledge towards developing targeted therapeutic approaches. Increased attention to this important but understudied field can help overcome existing barriers to progress and pave the way to novel therapeutic approaches with increased efficacy and fewer side effects than current options. The research teams comprising the Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium will take a comprehensive approach to understanding the biology of fusion oncoproteins in childhood cancers and will use this information to inform strategies for therapeutic targeting. This funding opportunity was announced on August 4, 2017. The application deadline is November 15, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: NIBIB Exploratory/Developmental Research Grant Program (R21)                       

Funding Opportunity Number: PAR-17-441

This FOA will support exploratory/developmental research programs of interest to the NIBIB.  These studies are expected to lead to breakthroughs in development of innovative techniques, agents, methodologies, models, or their applications. These studies may involve considerable risk that should be balanced by the potential high impact on human-health and related research. Applicants are expected to propose novel biomedical research approaches for which there are no preliminary data to demonstrate the feasibility of the proposed project. A project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. This funding opportunity was announced on August 4, 2017. The application deadline is September 7, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)

Funding Opportunity Number: PA-17-440

The purpose of this funding opportunity announcement (FOA) is to stimulate research in the interplay between cell death pathways in nave and drug resistant cancers. Regulated cell death, especially apoptosis and necroptosis, are natural barriers that restrict malignant cells from surviving and disseminating. Evasion of cell death mechanisms is one of the hallmarks of cancer contributing to tumor progression, metastases and resistance to therapy. Recent studies show that the machinery to activate different forms of cell death coexists in cells but the crosstalk of cell death pathways in cancer has not been systematically studied. Research into the intersection of cell death programs will allow for better defining markers of cell death pathway at the molecular level and offers the possibility that the specific mediators of cell survival may be inhibited and/or the mediators of cell death enhanced, driving nave and drug resistant cancer cells toward effective cell death. This funding opportunity was announced on August 4, 2017. The application deadline is September 7, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

HHS: The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)

Funding Opportunity Number: PA-17-449

The purpose of this funding opportunity announcement (FOA) is to stimulate research in the interplay between cell death pathways in nave and drug resistant cancers. Regulated cell death, especially apoptosis and necroptosis, are natural barriers that restrict malignant cells from surviving and disseminating. Evasion of cell death mechanisms is one of the hallmarks of cancer contributing to tumor progression, metastases and resistance to therapy. Recent studies show that the machinery to activate different forms of cell death coexists in cells but the crosstalk of cell death pathways in cancer has not been systematically studied. Research into the intersection of cell death programs will allow for better defining markers of cell death pathway at the molecular level and offers the possibility that the specific mediators of cell survival may be inhibited and/or the mediators of cell death enhanced, driving nave and drug resistant cancer cells toward effective cell death. This funding opportunity was announced on August 4, 2017. The application deadline is September 7, 2020. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

USAID Funding Opportunity Announcements:

 

USAID: Strengthening Egypt’s Family Planning Program       

Funding Opportunity Number: RFA-263-17-000004

The “Strengthening Egypt’s Family Planning Program” (SEFPP) Activity will provide technical assistance and training in support of Egypt’s Family Planning/Reproductive Health (FP/RH) Program. It is anticipated that the focused interventions under SEFPP will result in increasing demand for FP services and improving the quality of services and ultimately will lead to a positive change in contraceptive use and in reducing fertility over time. The SEFPP will build upon the work of ongoing health activities to the extent feasible. The focus of implementation of the SEFPP Activity will be on the nine governorates of Upper Egypt1 and the slum areas of Cairo and Alexandria. These geographic areas have the highest Total Fertility Rate (TFR) and comparatively low Contraceptive Prevalence Rate (CPR). Support to these governorates will focus on increasing availability and access to high impact interventions in reproductive health as well as ensuring the quality of family planning service provision. Improving the adoption of health behaviors through social and behavior change communication (SBCC) is another major area of emphasis in these governorates. Policy improvement work will have a national focus. FP/RH activities, with varying modalities, may extend to other governorates. Sustainability of activity interventions is a priority. Monitoring, evaluation, and special studies will be conducted throughout implementation in keeping with that goal. This funding opportunity was announced on August 2, 2017. The application deadline is September 25, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page.

 

United States Department of State Funding Opportunity Announcements:

 

DOS: PEPFAR Uganda Community Grants to Combat HIV/AIDS          

Funding Opportunity Number: DOS-KAM-SMGCG-FY18

U.S. Embassy, Kampala PEPFAR Uganda Small Grants Office is pleased to announce that funding is available through its Community Grants to Combat HIV/AIDS program. This is an open competition. PEPFAR Uganda invites proposals for projects that promote HIV/AIDS prevention, care and treatment in Uganda. BENEFICIARIES Targeted beneficiaries of the PEPFAR Uganda Community Grants to Combat HIV/AIDS for this proposal include the following: 1. Orphans and Vulnerable Children (OVCs) 2. Key Populations (KPs) 3. Men and Young Males The Small Grants Office welcomes applications from registered non-profit Ugandan organizations such as Community Based Organizations (CBO), Faith Based Organizations (FBO), or Non-Governmental Organizations (NGO). This funding opportunity was announced on August 1, 2017. The application deadline is October 31, 2017. For more information, see the “Related Documents” tab on the Grant Opportunity Page


Association Management Software Powered by YourMembership  ::  Legal